Reuters logo
BRIEF-Chemed reports Q3 earnings per share $2.13
October 26, 2017 / 8:39 PM / 2 months ago

BRIEF-Chemed reports Q3 earnings per share $2.13

Oct 26 (Reuters) - Chemed Corp

* Chemed reports third-quarter 2017 results

* Sees FY 2017 adjusted earnings per share $8.35 to $8.40 excluding items

* Q3 adjusted earnings per share $2.15

* Q3 gaap earnings per share $2.13

* Q3 earnings per share view $2.01 -- Thomson Reuters I/B/E/S

* Chemed Corp - qtrly ‍revenue increased 6.3% to $417 million​

* Q3 revenue view $413.8 million -- Thomson Reuters I/B/E/S

* Chemed Corp qtrly ‍vitas net patient revenue of $289 million, an increase of 2.2%​

* Chemed Corp - ‍roto-rooter is forecasted to achieve full-year 2017 revenue growth of 13% to 14%​

* Chemed Corp - ‍adjusted ebitda margin for roto-rooter​ for 2017 is estimated at 22.5%

* Chemed Corp - ‍revenue growth for vitas in 2017, prior to medicare cap, is estimated to be in range of 2% to 3%​

* Chemed Corp - ‍admissions and average daily census for vitas in 2017 are estimated to expand approximately 2% to 3%​

* Chemed Corp - ‍full-year 2017 adjusted ebitda margin for vitas, prior to medicare cap, is estimated to be 15.0% ​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below